AzTrials
AzTrials

Dehydration (Physiology)TRACENCT06858904

Rehydration With a Trace Mineral Supplement

A study testing ConcenTrace and ZeroLyte in people with Dehydration (Physiology), run by Arizona State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

It is well established that post-exercise rehydration with electrolyte solutions is more effective than plain water. However, most commercially available drinks are high in electrolytes but lack some essential trace minerals. Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Dehydration (Physiology)
What is being tested?
ConcenTrace and ZeroLyte
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
15 participants
Where
1 siteUnited States
Study dates
26 Mar 2025to 29 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Recreationally physically active: Training > 2x per week and ≤ 6hours per week
  • BMI of 18.5-29.9
  • Stable weight for the last 2 months (<5 pounds. fluctuation)

Who cannot join

  • Women who are pregnant, breast feeding, or planning to become pregnant during the trial
  • night shifting work
  • thyroid medication
  • bariatric surgery
  • cardiovascular disease
  • renal disease
Show all 13Show fewer
  • hepatic disease
  • Participating in another study at the same time
  • Bodyweight <110 pounds
  • Currently Smoker
  • Major surgery, including abdominal, in the past 3 months or individuals who have planned surgery during the trial.
  • Alcohol or drug abuse within the last 12 months
  • High alcohol intake (average of > 2 standard drinks per day or > 10 standard drinks per week)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Hydration Science Lab

    Phoenix, Arizona, 85004

Other trials in United States

About this study

It is well established that post-exercise rehydration with electrolyte solutions is more effective than plain water. However, most commercially available drinks are high in electrolytes but lack some essential trace minerals. This study aims to examine the impact of a higher-electrolyte sports drink compared with a low-electrolyte, trace-mineral-rich solution and water on the time course and extent of rehydration after exercise-induced dehydration.

Read the detailed description

Protocol Before the start of the study eligible participants will visit our lab to conduct a screening of medical history, weight, height, and a onetime assessment of body composition via BIA and Training history. This visit will take place at least one day before the actual start of the study and typically lasts no longer than 30 minutes. During this visit participants will be given two questionnaires, one regarding the physical activity readiness of the participant, and another one regarding their health history. If a participant does not meet the physical criteria and does not pass both questionnaires, they will be given a $25 digital Tango gift card for their brief visit to our lab. Participants who do pass will be given a scheduled date and time to visit the lab again for their first official trial.

At the start of the study subjects will visit the lab after at least 10h of fast and they will consume a light breakfast. An intravenous catheter will be place in an antecubital vein and a blood sample will be taken after 20 min for baseline. A baseline skin hydration reading will also be taken at this time. Subjects will void their bladders and a body weight will be taken.

Dehydration:

Consistent with the study by Shirreffs et al (2007) and based on our previous work, dehydration will be accomplished on the morning of testing via mild exercise and heat exposure to elicit a body weight loss of -2%. The subjects will perform four bouts of 25-minutes low-intensity exercise and 5 min rest (alternating cycling \& walking) or till they reach -2% of body weight dehydration.

Rehydration:

Upon losing 2% body weight, participants will be instructe to rinse off their face to get rid of excess sweat. This is followed by a 20 minutes rest period in a thermo-comfortable environment, a dehydrated baseline blood sample will be taken, along with a dehydrated skin hydration reading and subject will start the rehydration protocol.

The volunteers will consume one of the three drinks below in a cross over balance mode. During the first hour four equal doses will be consumed in15-minutes intervals at a total volume of 150% of their body weight loss.

Trials/Drinks (block randomization will be used to assign individual participants to each specific trial/drink using their ID number):

  • Water
  • ConcenTrace®
  • ZEROLyte™ Note: The beverage volumes will be standardized at 150% of body weight loss during exercise-induced dehydration to ensure consistency across trials.

See the study design expressed as a figure below:

Measurements:

All measurements will be performed at one of the test rooms at our lab facility that boarders the room where participants can relax and wait out the end of the study day. When certain measurements need to be performed they simply move from one room to the next. Duration of taking blood and urine samples will take not more than 30-90 seconds each and perceptual data will take 30-60 seconds to be reported. To allow to perform all measurements, participants will remain supervised by a team member in the lab for up to 7 hours per trial. Therefore, there will be a separate space available that allows for self-study or watching TV that includes a chair and table to work on and a couch to relax.

Blood samples (7 per trial):

Blood samples will be taken via a venous catheter attached to an extension tube and a stopcock. After each blood sample sterile saline solution will be infused in the extention tube to avoid clotting. The iv catheter will be placed by one of the Clinical Research Center phlebotomists. A total of seven 10 milliliters blood samples will be collected on the euhydrated baseline, dehydrated baseline and at 30, 60, 120, 180, and 240 minutes of the rehydration period.

All samples will be analyzed for glucose, osmolality, total plasma protein, hematocrit, hemoglobin (for plasma volume changes), sodium, potassium, and chloride.

Urine samples (6 per trial):

Urine samples will be provided from the subjects in a urine cup. The cup will be placed in the pass-through window where a lab technician will receive it and process it.

Urine samples will be collected using ~900 milliliters cups at euhydrated baseline, dehydrated baseline and cumulative totals will be collected at 60, 120, 180, and 240 minutes of the rehydration period. All samples will be analyzed for urine osmolality, specific gravity, volume, sodium, and potassium.

Sweat samples (1 per trial):

Sweat samples will be collected with sweat patches. The sweat patches are like a band-aid that it will be placed on the forearm and stay there for approximately 30 min to absorb sweat. After 30 minutes the patch will be removed and the sweat sample will be extracted by centrifugation in the lab.

Sweat samples will be collected during the first 30 min of exercise to assess sodium and potassium content.

Skin Hydration (6 per trial):

Skin hydration will be measured with a pen-like instrument that applies a very light pressure on the skin. This does not cause any pain or skin irritation.

Skin hydration will be measured on the face (inner zygomatic bone), arm (bicep brachii) at euhydrated baseline, 30 minutes after the end of dehydration, and at 60, 120, 180, and 240 minutes of rehydration.

Gastrointestinal Symptoms (6 per trial):

Gastrointestinal symptoms will be assessed at 1, 2, 3 and 4 hours of rehydration via Gastrointestinal Symptom Rating Scale (GSRS).

Perceptual Data (6 per trial, maximal 9 minutes):

Thirst, stomach fullness, and taste, assessed via a visual analog scale.

Being tested
Placebo, ConcenTrace, ZeroLyte
Keywords
rehydration, sports drinks, fluid balance, water retention
Medical subject headings
Dehydration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PlaceboDietary supplement

    Non- calorically sweetened Water

  • ConcenTraceDietary supplement

    1.25 milliliter of concentrace per liter

  • ZeroLyteDietary supplement

    Beverage with 1 pack of ZeroLyte per 500 milliliter of water

Study groups in NCT06858904
Study groupRoleWhat they receive
ConcenTraceExperimentalBeverage with ConcenTrace minerals
Receives: Dietary Supplement: ConcenTrace
ZeroLyteExperimentalBeverage with high level of trace elements but no sugar
Receives: Dietary Supplement: ZeroLyte
PlaceboPlacebo comparatorWater with non caloric, non-sodium containing sweetner
Receives: Dietary Supplement: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Net Fluid Balance

    Body water Retention after exercise-induced dehydration

    Measured: at 60 minutes, 120 minutes, 180 minutes and 240 minutes of rehydration

  2. Urine volume

    Urine volume during the rehydration period

    Measured: 1, 2, 3, and 4 hour of the rehydration period

  3. Free water clearance

    Free water clearance during the rehydration period

    Measured: 1, 2, 3, and 4 hours of the rehydration period

  4. Osmotic Clearance

    Osmotic renal clearance during the rehydration period

    Measured: 1, 2, 3, and 4 hours of the rehydration period

  5. Skin Hydration

    Skin hydration at the face assessed with a moisture meter.

    Measured: 1, 2, 3, and 4 hours of the rehydration period

Secondary outcomes (4)
  1. Plasma Volume

    Changes in Plasma Volume during rehydration based on hematocrit and hemoglobin

    Measured: 1, 2, 3, and 4 hours of the rehydration period

  2. Stomach fullness

    Stomach fullness assessed during dehydration

    Measured: 1, 2, 3, and 4 hours of the rehydration period

  3. Gastrointestinal symptoms

    Gastrointestinal symptoms assessed with the structured assessment of gastrointestinal symptoms scale

    Measured: At the end of the 4 hours rehydration period

  4. Plasma Osmolality

    Plasma osmolality during rehydration

    Measured: 1, 2, 3, and 4 hours of the rehydration period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Mar 2025
  2. Study start26 Mar 2025
  3. Primary completion29 Aug 2025
  4. Study completion29 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06858904
Sponsor's protocol ID
STUDY00021498
Acronym
TRACE
Status last verified
Sep 2025
First submitted
28 Feb 2025
Last updated
5 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing ConcenTrace and ZeroLyte in people with Dehydration (Physiology), run by Arizona State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Net Fluid Balance (time frame: at 60 minutes, 120 minutes, 180 minutes and 240 minutes of rehydration). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in